Search Results

Trinity Biotech plc, a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, will report financial results for the first quarter 2024 on Thursday, May 23, 2024 at 8:30 AM ET.

Trinity Biotech plc will report financial results for the fourth quarter and fiscal year 2023 on Thursday, April 4, 2024 at 8:00 AM ET.

Trinity Biotech plc a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, announced steps to advance its next generation continuous glucose monitoring solution towards market launch.

Trinity Biotech Plc. announced that it has finalized the effective date of its ratio change of its American depositary shares from one ADS representing four Class A ordinary shares to one ADS representing twenty Class A ordinary shares.

Trinity Biotech Plc. announced that it plans to change the ratio of the American depositary shares representing its Class A ordinary shares from one ADS representing four Class A ordinary share to one ADS representing twenty Class A ordinary shares.

Trinity Biotech plc announced a strategic collaboration with medical artificial intelligence company PulseAI to enhance the Company’s recently acquired continuous glucose monitor biosensor technology.

Trinity Biotech plc, a leading developer and manufacturer of diagnostic solutions for the point-of-care and clinical laboratory markets, will host an investor call on Wednesday, January 31 at 8:30 AM ET to provide an update on business operations.

Trinity Biotech plc a commercial stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, announced the launch of its continuous glucose monitoring microsite.

Trinity Biotech plc, a commercial stage biotechnology company focused on diabetes management solutions and human diagnostics, including wearable biosensors, announces that its senior management team plans to attend the 84th Scientific Sessions of the American Diabetes Association in Orlando Florida, taking place on June 21-24, 2024.